Form D · Pharmaceuticals
Serenity Pharmaceuticals LLC
Brooklyn, NY · CIK 0001674920
Offering snapshot reported Jul 1, 2016 · SEC filing
- Reported sold
- $7.89M Offering amount: $10M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 1, 2016 | Initial | $7,893,932 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-266280
Source: Form D, filed Jul 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Etkind | Director |
| Samuel Herschkowitz | Director, Executive |
| Alain Kodsi | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
122 Willow Street
Brooklyn, NY, 11201
Brooklyn, NY, 11201